Genetic insights into the timing of metastasis: a secondary analysis of the Count Me In metastatic breast cancer cohort (opens in new tab)

IntroductionMetastatic breast cancer is incurable, associated with poor outcomes, and expected to increase in both incidence and cost.MethodsWe conducted a secondary analysis of retrospectively ascertained time-to-event outcomes within a cross-sectional genomic dataset linked to medical and self-reported patient data from the Count Me In: The Metastatic Breast Cancer Project (CMI-MBCProject), available through dbGaP (phs001709.v1.p1). Whole-exome sequencing data derived from saliva samples we...